arrow
R

Romain Gasser

toulouse institute for infectious and inflammatory diseases
H指数:27
被引数:3,044

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety, pharmacokinetics, and biological activity of CD4-mimetic BNM-III-170 in SHIV-infected rhesus macaques
2025-04-010
OAAI
Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity

小CD4模拟物使HIV-1-infected巨噬细胞对抗体依赖性细胞毒性敏感

2023-01-018
OAAI
Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays (vol 9, e00886-21, 2021)
2022-08-310
OAAI
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen
2022-06-0114
OAAI
Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4+ T Cell

通过流式细胞术检测HIV-1辅助蛋白Nef和Vpu代表了一种研究其在单个感染的CD4 T细胞中功能相互作用的新工具

2022-03-239
OA
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection

Fc增强的NTD结合非中和抗体延迟病毒扩散,并与nAb协同保护小鼠免受致死性SARS-CoV-2感染

2022-02-0183
OAAI
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern

两种广泛中和抗体针对SARS-CoV-2令人关注的新兴变体的结构基础和作用方式

2022-01-0188
OAAI
Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality
2021-11-2626
OAAI
Across Functional Boundaries: Making Nonneutralizing Antibodies To Neutralize HIV-1 and Mediate Fc-Mediated Effector Killing of Infected Cells

跨功能边界: 制备非中和抗体以中和HIV-1并介导Fc介导的效应子对感染细胞的杀伤

MBIO
IF4.7
2021-10-267
OAAI
Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2

温度对SARS-CoV-2刺突糖蛋白与宿主ACE2亲和力的影响

2021-10-0142
OAAI
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy

小鼠SARS-CoV-2感染的实时成像显示,中和抗体需要Fc功能才能获得最佳疗效

IMMUNITY
IF26.3
2021-09-01121
OAAI
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
2021-06-0191
OAAI
Evaluation of a Commercial Culture-Free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison With an Antireceptor-Binding Domain Enzyme-Linked Immunosorbent Assay
2021-04-3024
OAAI
Mechanisms of HIV-1 evasion to the antiviral activity of chemokine CXCL12 indicate potential links with pathogenesis
2021-04-1913
OAAI
Identification of SARS-CoV-2-specific immune alterations in acutely ill patients
2021-04-1522
OA
Multicenter Evaluation of the Clinical Performance and the Neutralizing Antibody Activity Prediction Properties of 10 High-Throughput Serological Assays Used in Clinical Laboratories
2021-02-1820
OAAI